ANXIETY, DEPRESSION AND QUALITY OF LIFE IN PATIENTS WITH GLAUCOMA
Abstract
Previous studies have shown significant comorbidity between depressive, anxious disorders, and glaucoma, which is the second most common cause of vision loss in the world. This study aimed to determine the presence of depression and anxiety, assess of the quality of life in patients with glaucoma, as well as to compare with the results of the healthy population. Cross-sectional study, was carried out at the Ophthalmology Clinic, of the University Clinical Center Niš. The presence of anxiety, and depression, were evaluated by Zung’s self-rating instruments for anxiety, and depression, and the quality of life was evaluated by the WHO Quality of life instrument-Brief version. Sociodemographic and glaucoma-related parameters were gathered. Around 38.64% of patients with glaucoma presented depression, mostly mild and moderate forms, while mild depression was found in 4.17% of respondents in the control group. The number of patients with anxiety was two times higher in the experimental than in the control group. Mentioned results show a statistically relevant difference (p < 0.01). We determined a statistically relevant correlation between the frequency of depression and the severity of glaucoma (p < 0.001), while no such correlation was found between anxiety and the severity of glaucoma (p > 0.05). While comparing the gathered values for each domain as well as the overall QOL we found a statistically relevant difference (p < 0.001). A statistically relevant correlation was found between the patients with milder and more severe glaucoma forms. Comorbid depression and anxiety in patients with glaucoma occur in more severe forms of glaucoma, in patients with a longer duration of the disease for medical and psycho-social reasons.
References
Normal
0
false
false
false
EN-US
X-NONE
X-NONE
DefSemiHidden="false" DefQFormat="false" DefPriority="99"
LatentStyleCount="371">
UnhideWhenUsed="true" QFormat="true" Name="heading 2"/>
UnhideWhenUsed="true" QFormat="true" Name="heading 3"/>
UnhideWhenUsed="true" QFormat="true" Name="heading 4"/>
UnhideWhenUsed="true" QFormat="true" Name="heading 5"/>
UnhideWhenUsed="true" QFormat="true" Name="heading 6"/>
UnhideWhenUsed="true" QFormat="true" Name="heading 7"/>
UnhideWhenUsed="true" QFormat="true" Name="heading 8"/>
UnhideWhenUsed="true" QFormat="true" Name="heading 9"/>
Name="index 1"/>
Name="index 2"/>
Name="index 3"/>
Name="index 4"/>
Name="index 5"/>
Name="index 6"/>
Name="index 7"/>
Name="index 8"/>
Name="index 9"/>
UnhideWhenUsed="true" Name="toc 1"/>
UnhideWhenUsed="true" Name="toc 2"/>
UnhideWhenUsed="true" Name="toc 3"/>
UnhideWhenUsed="true" Name="toc 4"/>
UnhideWhenUsed="true" Name="toc 5"/>
UnhideWhenUsed="true" Name="toc 6"/>
UnhideWhenUsed="true" Name="toc 7"/>
UnhideWhenUsed="true" Name="toc 8"/>
UnhideWhenUsed="true" Name="toc 9"/>
Name="Normal Indent"/>
Name="footnote text"/>
Name="annotation text"/>
Name="header"/>
Name="footer"/>
Name="index heading"/>
UnhideWhenUsed="true" QFormat="true" Name="caption"/>
Name="table of figures"/>
Name="envelope address"/>
Name="envelope return"/>
Name="footnote reference"/>
Name="annotation reference"/>
Name="line number"/>
Name="page number"/>
Name="endnote reference"/>
Name="endnote text"/>
Name="table of authorities"/>
Name="macro"/>
Name="toa heading"/>
Name="List"/>
Name="List Bullet"/>
Name="List Number"/>
Name="List 2"/>
Name="List 3"/>
Name="List 4"/>
Name="List 5"/>
Name="List Bullet 2"/>
Name="List Bullet 3"/>
Name="List Bullet 4"/>
Name="List Bullet 5"/>
Name="List Number 2"/>
Name="List Number 3"/>
Name="List Number 4"/>
Name="List Number 5"/>
Name="Closing"/>
Name="Signature"/>
UnhideWhenUsed="true" Name="Default Paragraph Font"/>
UnhideWhenUsed="true" Name="Body Text"/>
Name="Body Text Indent"/>
Name="List Continue"/>
Name="List Continue 2"/>
Name="List Continue 3"/>
Name="List Continue 4"/>
Name="List Continue 5"/>
Name="Message Header"/>
Name="Salutation"/>
Name="Date"/>
Name="Body Text First Indent"/>
Name="Body Text First Indent 2"/>
Name="Note Heading"/>
Name="Body Text 2"/>
Name="Body Text 3"/>
Name="Body Text Indent 2"/>
Name="Body Text Indent 3"/>
Name="Block Text"/>
Name="Hyperlink"/>
Name="FollowedHyperlink"/>
Name="Document Map"/>
Name="Plain Text"/>
Name="E-mail Signature"/>
Name="HTML Top of Form"/>
Name="HTML Bottom of Form"/>
Name="Normal (Web)"/>
Name="HTML Acronym"/>
Name="HTML Address"/>
Name="HTML Cite"/>
Name="HTML Code"/>
Name="HTML Definition"/>
Name="HTML Keyboard"/>
Name="HTML Preformatted"/>
Name="HTML Sample"/>
Name="HTML Typewriter"/>
Name="HTML Variable"/>
Name="Normal Table"/>
Name="annotation subject"/>
Name="No List"/>
Name="Outline List 1"/>
Name="Outline List 2"/>
Name="Outline List 3"/>
Name="Table Simple 1"/>
Name="Table Simple 2"/>
Name="Table Simple 3"/>
Name="Table Classic 1"/>
Name="Table Classic 2"/>
Name="Table Classic 3"/>
Name="Table Classic 4"/>
Name="Table Colorful 1"/>
Name="Table Colorful 2"/>
Name="Table Colorful 3"/>
Name="Table Columns 1"/>
Name="Table Columns 2"/>
Name="Table Columns 3"/>
Name="Table Columns 4"/>
Name="Table Columns 5"/>
Name="Table Grid 1"/>
Name="Table Grid 2"/>
Name="Table Grid 3"/>
Name="Table Grid 4"/>
Name="Table Grid 5"/>
Name="Table Grid 6"/>
Name="Table Grid 7"/>
Name="Table Grid 8"/>
Name="Table List 1"/>
Name="Table List 2"/>
Name="Table List 3"/>
Name="Table List 4"/>
Name="Table List 5"/>
Name="Table List 6"/>
Name="Table List 7"/>
Name="Table List 8"/>
Name="Table 3D effects 1"/>
Name="Table 3D effects 2"/>
Name="Table 3D effects 3"/>
Name="Table Contemporary"/>
Name="Table Elegant"/>
Name="Table Professional"/>
Name="Table Subtle 1"/>
Name="Table Subtle 2"/>
Name="Table Web 1"/>
Name="Table Web 2"/>
Name="Table Web 3"/>
Name="Balloon Text"/>
Name="Table Theme"/>
Name="List Paragraph"/>
Name="Intense Quote"/>
Name="Subtle Emphasis"/>
Name="Intense Emphasis"/>
Name="Subtle Reference"/>
Name="Intense Reference"/>
UnhideWhenUsed="true" Name="Bibliography"/>
UnhideWhenUsed="true" QFormat="true" Name="TOC Heading"/>
Name="Grid Table 1 Light Accent 1"/>
Name="Grid Table 6 Colorful Accent 1"/>
Name="Grid Table 7 Colorful Accent 1"/>
Name="Grid Table 1 Light Accent 2"/>
Name="Grid Table 6 Colorful Accent 2"/>
Name="Grid Table 7 Colorful Accent 2"/>
Name="Grid Table 1 Light Accent 3"/>
Name="Grid Table 6 Colorful Accent 3"/>
Name="Grid Table 7 Colorful Accent 3"/>
Name="Grid Table 1 Light Accent 4"/>
Name="Grid Table 6 Colorful Accent 4"/>
Name="Grid Table 7 Colorful Accent 4"/>
Name="Grid Table 1 Light Accent 5"/>
Name="Grid Table 6 Colorful Accent 5"/>
Name="Grid Table 7 Colorful Accent 5"/>
Name="Grid Table 1 Light Accent 6"/>
Name="Grid Table 6 Colorful Accent 6"/>
Name="Grid Table 7 Colorful Accent 6"/>
Name="List Table 1 Light Accent 1"/>
Name="List Table 6 Colorful Accent 1"/>
Name="List Table 7 Colorful Accent 1"/>
Name="List Table 1 Light Accent 2"/>
Name="List Table 6 Colorful Accent 2"/>
Name="List Table 7 Colorful Accent 2"/>
Name="List Table 1 Light Accent 3"/>
Name="List Table 6 Colorful Accent 3"/>
Name="List Table 7 Colorful Accent 3"/>
Name="List Table 1 Light Accent 4"/>
Name="List Table 6 Colorful Accent 4"/>
Name="List Table 7 Colorful Accent 4"/>
Name="List Table 1 Light Accent 5"/>
Name="List Table 6 Colorful Accent 5"/>
Name="List Table 7 Colorful Accent 5"/>
Name="List Table 1 Light Accent 6"/>
Name="List Table 6 Colorful Accent 6"/>
Name="List Table 7 Colorful Accent 6"/>
/* Style Definitions */
table.MsoNormalTable
{mso-style-name:"Table Normal";
mso-tstyle-rowband-size:0;
mso-tstyle-colband-size:0;
mso-style-noshow:yes;
mso-style-priority:99;
mso-style-parent:"";
mso-padding-alt:0in 5.4pt 0in 5.4pt;
mso-para-margin-top:0in;
mso-para-margin-right:0in;
mso-para-margin-bottom:8.0pt;
mso-para-margin-left:0in;
line-height:107%;
mso-pagination:widow-orphan;
font-size:11.0pt;
font-family:"Calibri","sans-serif";
mso-ascii-font-family:Calibri;
mso-ascii-theme-font:minor-latin;
mso-hansi-font-family:Calibri;
mso-hansi-theme-font:minor-latin;
mso-bidi-font-family:"Times New Roman";
mso-bidi-theme-font:minor-bidi;}
Agorastos A, Skevas C, Matthaei M, Otte C, Klemm M, Richard G et al: Depression, anxiety, and disturbed sleepin glaucoma. J Neuropsychiatry Clin Neurosci 2013;25:205-13. [CrossRef] [PubMed]
Bali SJ, Parmar T, Arora V, et al. Evaluation of major depressive disorder in patients receiving chronic treat-ment with topical timolol. Ophthalmologica 2011;226: 157-60. [CrossRef] [PubMed]
Fasih U, Hamirani MM, Jafri AR, et al. Assessment of anxiety and depression in primary open angle glaucoma patients (a study of 100 cases). Pak J Ophthalmol 2010;26:143-7.
Kong X, Yan M, Sun X, Xiao Z: Anxiety and De-pression are More Prevalent in Primary Angle Closure Glaucoma Than in Primary Open-Angle Glaucoma. J Glaucoma 2015;24(5):e57-63.24. [CrossRef] [PubMed]
Kong XM, Zhu WQ, Hong JX, Sun XH: Is glaucoma comprehension associated with psychological disturb-ance and vision-related quality of life for patients with glaucoma? A cross-sectional study. BMJ Open 2014; 26:4(5):e004632. [CrossRef] [PubMed]
Lim NC, Fan CH, Yong MK et al. Assessment of Depression, Anxiety, and Quality of Life in Singapo-rean Patients With Glaucoma. J Glaucoma 2016; 25(7):1605-12. [CrossRef] [PubMed]
Loon SC, Jin J, Jin Goh M. The relationship between quality of life and adherence to medication in glaucoma patients in Singapore. J Glaucoma 2015;24: e36-e42. [CrossRef] [PubMed]
Mabuchi F, Yoshimura K, Kashiwagi K, et al. High prevalence of anxiety and depression in patients with primary open-angle glaucoma. J Glaucoma 2008;17: 552-7. [CrossRef] [PubMed]
Mabuchi F, Yoshimura K, Kashiwagi K, et al. Risk factors for anxiety and depression in patients with glaucoma. Br J Ophthalmol 2012;96:821-5. [CrossRef] [PubMed]
Marić V. Ispitivanje prediktora za nastanak pseudo-eksfolijativnog glaukoma. Doktorska disertacija. Univerzitet u Beogradu Medicinski fakultet; 2019.
Pelcic G, Ljubicic R, Barac J. et al. Glaucoma, depression and quality of life: Multiple comorbidities, multiple assessments and multidisciplinary plan treat-ment. Psychiatria Danubina 2017;29(3):351-9. [CrossRef] [PubMed]
Pop-Jordanova N, Ristova J, Loleska S: Depression in ophthalmological patients. Prilozi 2014;35(2):53-8. [CrossRef] [PubMed]
Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. The British Journal of Ophthalmology 2006;90(3): 262-7. [CrossRef] [PubMed]
Ramulu PY, Swenor BK, Jefferys JL, et al. Difficulty with outloud and silent reading in glaucoma. Invest Ophthalmol Vis Sci 2013;54:666-72. [CrossRef] [PubMed]
Ramulu PY, West SK, Munoz B, et al. Driving cessation and driving limitation in glaucoma: the Salisbury Eye Evaluation Project. Ophthalmology 2009;116:1846-53. [CrossRef] [PubMed]
Skalicky S, Goldberg I. Depression and quality of life in patients with glaucoma: a cross-sectional analysis using the Geriatric Depression Scale-15, assessment of function related to vision, and the Glaucoma Quality of Life-15. J Glaucoma 2008;17:546-51. [CrossRef] [PubMed]
Tastan S, Iyigun E, Bayer A, et al. Anxiety, depression and quality of life in Turkish patients with glaucoma. Psychol Rep 2010;106:343-57. [CrossRef] [PubMed]
Wang SY, Singh K, Lin SC. Prevalence and predictors of depression among participants with glaucoma in a nationally representative population sample. Am J Ophthalmol 2012;154:436-44. [CrossRef] [PubMed]
Zhou C, Qian S, Wu P, et al. Anxiety and depression in Chinese patients with glaucoma: sociodemographic, clinical and self-reported correlates. J Psychosom Res 2013;75:75-82. [CrossRef] [PubMed]